buprenorphine 2.9 MG / naloxone 0.71 MG [Zubsolv]

RxCUI
1666384
RxNorm name
buprenorphine 2.9 MG / naloxone 0.71 MG [Zubsolv]
Term type
SBDC
Status
Active
Updated
2026-11-19 17:14:53

RxNorm Status History#

Status
Active
Source
RXNORM
Current
YES
Release start
102015
Active start
102015
Multiple ingredient
YES
Branded
YES

Ingredients And Strength#

Ingredient, Strength, Base table
IngredientStrengthBaseBasis of strength
2.9 MG / 1 EACHbuprenorphine
0.71 MG / 1 EACHnaloxone

Derived Ingredient Concepts#

Ingredient, RxCUI table
IngredientRxCUI
buprenorphine1819
naloxone7242

Source Vocabulary Codes#

Code type, Values, Count table
Code typeValuesCountCategory
PRESCRIBABLEY1ATTRIBUTES
RXNAV_STRbuprenorphine 2.9 MG / naloxone 0.71 MG [Zubsolv]1NAMES
RxNorm Namebuprenorphine 2.9 MG / naloxone 0.71 MG [Zubsolv]1NAMES
TTYSBDC1ATTRIBUTES
RxCUI16663841CODES

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 0 matching rows.

No records found.

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
ATCV03ABAntidotesATC1-4naloxone
ATCN07BCDrugs used in opioid dependenceATC1-4buprenorphine
ATCN02AEOripavine derivativesATC1-4buprenorphine
ATCA06AHPeripheral opioid receptor antagonistsATC1-4naloxone
FDASPLN0000175691Opioid AntagonistEPChas_epcnaloxone
FDASPLN0000175689Partial Opioid AgonistEPChas_epcbuprenorphine
FDASPLN0000000154Opioid AntagonistsMOAhas_moanaloxone
FDASPLN0000175685Partial Opioid AgonistsMOAhas_moabuprenorphine
MEDRTD002047BuprenorphineCHEMhas_ingredientbuprenorphine
MEDRTD009270NaloxoneCHEMhas_ingredientnaloxone
MEDRTD004342Drug HypersensitivityDISEASEci_withnaloxone
MEDRTD004342Drug HypersensitivityDISEASEci_withbuprenorphine
MEDRTD006556Heroin DependenceDISEASEmay_treatbuprenorphine
MEDRTD009293Opioid-Related DisordersDISEASEmay_diagnosenaloxone
MEDRTD009293Opioid-Related DisordersDISEASEmay_treatnaloxone
MEDRTD010146PainDISEASEmay_treatbuprenorphine
MEDRTD012120Respiration DisordersDISEASEmay_treatnaloxone
MEDRTD012772Shock, SepticDISEASEmay_treatnaloxone
MEDRTN0000000154Opioid AntagonistsMOAhas_moabuprenorphine
MEDRTN0000000154Opioid AntagonistsMOAhas_moanaloxone
MEDRTN0000175685Partial Opioid AgonistsMOAhas_moabuprenorphine
MEDRTN0000175729Central Nervous System StimulationPEhas_penaloxone
MEDRTN0000008768Decreased Organized Electrical ActivityPEhas_pebuprenorphine
MEDRTN0000178478Increased Blood PressurePEhas_penaloxone
MEDRTN0000009393Increased Medullary Respiratory DrivePEhas_penaloxone

Properties#

Category, Property, Value table
CategoryPropertyValue
ATTRIBUTESGENERAL_CARDINALITYMULTI
ATTRIBUTESRXNAV_HUMAN_DRUGUS